A tetracycline analog improves acute respiratory distress syndrome survival in an ovine model

Annals of Thoracic Surgery

Volumn 90, Issue 2, 2010, Pages 419-426

  Zhou, Xiaoqin ^a   Wang, Dongfang ^a   Ballard Croft, Cherry K ^a   Simon, Sanford R ^b   Lee, Hsi Ming ^c   Zwischenberger, Joseph B ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; GELATINASE A; GELATINASE B; INCYCLINIDE; SOLUTOL HS 15;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTICLE; BURN; CARBON DIOXIDE BLOOD LEVEL; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL MODEL; FEMALE; LUNG ARTERY PRESSURE; LUNG BAROTRAUMA; LUNG BURN; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; SHEEP; SURVIVAL TIME;

ANIMALS; DISEASE MODELS, ANIMAL; RESPIRATORY DISTRESS SYNDROME, ADULT; SHEEP; SURVIVAL RATE; TETRACYCLINES;

EID: 77955697945     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2010.04.052     Document Type: Article

References (44)

1. T.C. Hollingsed, J.R. Saffle, R.G. Barton, W.B. Craft, and S.E. Morris Etiology and consequences of respiratory failure in thermally injured patients Am J Surg 166 1993 592 597
2. C. Brun-Buisson, C. Minelli, and G. Bertolini Epidemiology and outcome of acute lung injury in European intensive care units Results from the ALIVE study Intensive Care Med 30 2004 51 61
3. G.D. Rubenfeld, E. Caldwell, and E. Peabody Incidence and outcomes of acute lung injury N Engl J Med 353 2005 1685 1693
4. H.R. Bream-Rouwenhorst, E.A. Beltz, M.B. Ross, and K.G. Moores Recent developments in the management of acute respiratory distress syndrome in adults Am J Health Syst Pharm 65 2008 29 36
5. S.E. Erickson, G.S. Martin, J.L. Davis, M.A. Matthay, and M.D. Eisner Recent trends in acute lung injury mortality: 19962005 Crit Care Med 37 2009 1574 1579
6. J. Phua, J.R. Badia, and N.K.J. Adhikari Has mortality from acute respiratory distress syndrome decreased over time?: a systematic review Am J Respir Crit Care Med 179 2009 220 227
7. K. Raghavendran, G.S. Pryhuber, P.R. Chess, B.A. Davidson, P.R. Knight, and R.H. Notter Pharmacotherapy of acute lung injury and acute respiratory distress syndrome Curr Med Chem 15 2008 1911 1924
8. D.F. Willson, N.J. Thomas, and B.P. Markovitz Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial JAMA 293 2005 470 476
9. L.B. Ware, and M.A. Matthay The acute respiratory distress syndrome N Engl J Med 342 2000 1334 1349
10. I. Pallister, C. Dent, and N. Topley Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Crit Care Med 30 2002 1717 1721
11. S. Chakrabarti, and K.D. Patel Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology Exp Lung Res 31 2005 599 621
12. K. Torii, K. Iida, and Y. Miyazaki Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome Am J Respir Crit Care Med 155 1997 43 46
13. J. Pugin, G. Verghese, M.C. Widmer, and M.A. Matthay The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome Crit Care Med 27 1999 304 312
14. T. Keck, J.H. Balcom 4th, C. Fernndez-del Castillo, B.A. Antoniu, and A.L. Warshaw Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat Gastroenterology 122 2002 188 201
15. J. Lanchou, M. Corbel, and M. Tanguy Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients Crit Care Med 31 2003 536 542
16. S.E.G. Fligiel, T. Standiford, and H.M. Fligiel Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury Hum Pathol 37 2006 422 430
17. M.Y. Kong, A. Gaggar, Y. Li, M. Winkler, J.E. Blalock, and J.P. Clancy Matrix metalloproteinase activity in pediatric acute lung injury Int J Med Sci 6 2009 9 17
18. J. Steinberg, J. Halter, and H.J. Schiller Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats J Surg Res 111 2003 185 195
19. J. Steinberg, J. Halter, and H. Schiller Chemically modified tetracycline prevents the development of septic shock and acute respiratory distress syndrome in a clinically applicable porcine model Shock 24 2005 348 356
20. B.E. Muhs, S. Patel, H. Yee, S. Marcus, and P. Shamamian Inhibition of matrix metalloproteinases reduces local and distant organ injury following experimental acute pancreatitis J Surg Res 109 2003 110 117
21. T. Nakamura, Y. Kawagoe, and T. Matsuda Effect of polymyxin B-immobilized fiber on blood metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in acute respiratory distress syndrome patients Blood Purif 22 2004 256 260
22. J.H. Kim, M.H. Suk, and D.W. Yoon Inhibition of matrix metalloproteinase-9 prevents neutrophilic inflammation in ventilator-induced lung injury Am J Physiol Lung Cell Mol Physiol 291 2006 L580 L587
23. M. Sochor, S. Richter, A. Schmidt, S. Hempel, U.T. Hopt, and T. Keck Inhibition of matrix metalloproteinase-9 with doxycycline reduces pancreatitis-associated lung injury Digestion 80 2009 65 73
24. Y. Liu, N.S. Ramamurthy, and J. Marecek The lipophilicity, pharmacokinetics, and cellular uptake of different chemically-modified tetracyclines (CMTs) Curr Med Chem 8 2001 243 252
25. M.R. Acharya, J. Venitz, W.D. Figg, and A. Sparreboom Chemically modified tetracyclines as inhibitors of matrix metalloproteinases Drug Resist Updat 7 2004 195 208
26. S.M. Raulo, T. Sorsa, and P. Maisi In vitro inhibition of matrix metalloproteinase activity in tracheal epithelial lining fluid from horses with recurrent airway obstruction Am J Vet Res 67 2006 1252 1257
27. D.E. Carney, C.J. Lutz, and A.L. Picone Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass Circulation 100 1999 400 406
28. J.M. Halter, L.A. Pavone, and J.M. Steinberg Chemically modified tetracycline (COL-3) improves survival if given 12 but not 24 hours after cecal ligation and puncture Shock 26 2006 587 591
29. S.K. Alpard, J.B. Zwischenberger, W. Tao, D.J. Deyo, D.L. Traber, and A. Bidani New clinically relevant sheep model of severe respiratory failure secondary to combined smoke inhalation/cutaneous flame burn injury Crit Care Med 28 2000 1469 1476
30. NIH NHYLBI ARDS Clinical Network Mechanical Ventilation Protocol Summary http://www.ardsnet.org/system/files/6mlcardsmall-2008update-final-JULY2008.pdf Accessed May 17, 2010
31. C.S. Cox, J.B. Zwischenberger, D.L. Traber, L.D. Traber, A.K. Haque, and D.N. Herndon Heparin improves oxygenation and minimizes barotrauma after severe smoke inhalation in an ovine model Surg Gynecol Obstet 176 1993 339 349
32. R. Ruchatz, and H. Schuch Physicochemical properties of Solutol HS 15 and its solubilizates BASF ExAct 1 1998 6 7
33. K. Nishina, K. Mikawa, Y. Takao, N. Maekawa, M. Shiga, and H. Obara ONO-5046, an elastase inhibitor, attenuates endotoxin-induced acute lung injury in rabbits Anesth Analg 84 1997 1097 1103
34. M.L. Pearce, J.O.E. Yamashita, and J. Beazell Measurement of pulmonary edema Circ Res 16 1965 482 488
35. D.E. Carney, U.G. McCann, and H.J. Schiller Metalloproteinase inhibition prevents acute respiratory distress syndrome J Surg Res 99 2001 245 252
36. M.F. Swartz, J.M. Halter, and G.W. Fink Chemically modified tetracycline improves contractility in porcine coronary ischemia/reperfusion injury J Card Surg 21 2006 254 260
37. F. Mottu, M.-J. Stelling, D.A. Rfenacht, and E. Doelker Comparative hemolytic activity of undiluted organic water-miscible solvents for intravenous and intra-arterial injection PDA J Pharm Sci Technol 55 2001 16 23
38. H.-K. Ryoo, C.-W. Park, S.-C. Chi, and E.-S. Park Development of propofol-loaded microemulsion systems for parenteral delivery Arch Pharm Res 28 2005 1400 1405
39. C. Von Corswant, P. Thoren, and S. Engstrom Triglyceride-based microemulsion for intravenous administration of sparingly soluble substances J Pharm Sci 87 1998 200 208
40. R.G. Strickley Solubilizing excipients in oral and injectable formulations Pharm Res 21 2004 201 230
41. T. Iwata, M. Chiyo, and S. Yoshida Lung transplant ischemia reperfusion injury: metalloprotease inhibition down-regulates exposure of type V collagen, growth-related oncogene-induced neutrophil chemotaxis, and tumor necrosis factor-alpha expression Transplantation 85 2008 417 426
42. R.L. Zemans, S.P. Colgan, and G.P. Downey Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury Am J Respir Cell Mol Biol 40 2009 519 535
43. J. Cazalis, S. Tanabe, G. Gagnon, T. Sorsa, and D. Grenier Tetracyclines and chemically modified tetracycline-3 (CMT-3) modulate cytokine secretion by lipopolysaccharide-stimulated whole blood Inflammation 32 2009 130 137
44. C. Savage, J.B. Zwischenberger, D.J. Deyo, T.A. Heming, S.K. Alpard, and A. Bidani New technique for performing bronchoalveolar lavage in sheep J Bronchol 8 2001 17 20